NASH/MASH
Study Details
Non-Alcoholic Steatohepatitis (NASH) and Metabolic Associated Steatohepatitis (MASH) are severe forms of fatty liver disease, affecting millions of people worldwide. These conditions involve liver inflammation and damage due to fat accumulation, not caused by alcohol consumption. NASH/MASH can lead to serious health complications, including liver fibrosis, cirrhosis, liver failure, and an increased risk of liver cancer.
In its early stages, NASH/MASH may present with few or no symptoms, often detected incidentally during routine medical tests. As the disease progresses, individuals may experience fatigue, weakness, and discomfort in the upper right abdomen. Effective management of NASH/MASH involves lifestyle changes such as weight loss, a healthy diet, and regular exercise. Emerging therapies are also being developed to target liver inflammation and fibrosis directly.
At Epic Medical Research, we are dedicated to advancing the understanding and treatment of NASH/MASH through clinical trials. Qualified research participants will receive financial compensation for their time and travel, study-related medical and psychological evaluations by our expert doctors, and access to the investigative study medications at no cost. Your participation helps pave the way for new treatments and a better understanding of NASH/MASH, contributing to the future of medical research and improved patient outcomes. Join us in our mission to combat NASH/MASH through clinical trial participation!
To Qualify:
Age: 18-75 Years
BMI: ≥25.0 and <50.0
Call us to learn more about inclusion criteria
Please fill out below mentioned form or call us at (972) 782 - 2410 to learn more about Compensation details.
INTERESTED IN PARTICIPATING IN A CURRENT RESEARCH STUDY?
PLEASE CALL US ON (972) 782 - 2410
What our Patients are saying